231 related articles for article (PubMed ID: 35892705)
1. FcγR-Mediated Trogocytosis 2.0: Revisiting History Gives Rise to a Unifying Hypothesis.
Lindorfer MA; Taylor RP
Antibodies (Basel); 2022 Jul; 11(3):. PubMed ID: 35892705
[TBL] [Abstract][Full Text] [Related]
2. Measurement of Trogocytosis: Quantitative Analyses Validated with Rigorous Controls.
Taylor RP; Lindorfer MA
Curr Protoc; 2023 Oct; 3(10):e897. PubMed ID: 37830752
[TBL] [Abstract][Full Text] [Related]
3. Loss of CD20 and bound CD20 antibody from opsonized B cells occurs more rapidly because of trogocytosis mediated by Fc receptor-expressing effector cells than direct internalization by the B cells.
Beum PV; Peek EM; Lindorfer MA; Beurskens FJ; Engelberts PJ; Parren PW; van de Winkel JG; Taylor RP
J Immunol; 2011 Sep; 187(6):3438-47. PubMed ID: 21841127
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of Fcγ receptor-mediated trogocytosis-based false-positive results in flow cytometry.
Masuda S; Iwasaki S; Tomaru U; Sato J; Kawakami A; Ichijo K; Sogo S; Baba T; Katsumata K; Kasahara M; Ishizu A
PLoS One; 2012; 7(12):e52918. PubMed ID: 23300821
[TBL] [Abstract][Full Text] [Related]
5. Both activating and inhibitory Fc gamma receptors mediate rituximab-induced trogocytosis of CD20 in mice.
Boross P; Jansen JH; Pastula A; van der Poel CE; Leusen JH
Immunol Lett; 2012 Mar; 143(1):44-52. PubMed ID: 22285696
[TBL] [Abstract][Full Text] [Related]
6. Binding of rituximab, trastuzumab, cetuximab, or mAb T101 to cancer cells promotes trogocytosis mediated by THP-1 cells and monocytes.
Beum PV; Mack DA; Pawluczkowycz AW; Lindorfer MA; Taylor RP
J Immunol; 2008 Dec; 181(11):8120-32. PubMed ID: 19018005
[TBL] [Abstract][Full Text] [Related]
7. Fcγ-receptor-mediated trogocytosis impacts mAb-based therapies: historical precedence and recent developments.
Taylor RP; Lindorfer MA
Blood; 2015 Jan; 125(5):762-6. PubMed ID: 25498911
[TBL] [Abstract][Full Text] [Related]
8. The Role of Trogocytosis in the Modulation of Immune Cell Functions.
Miyake K; Karasuyama H
Cells; 2021 May; 10(5):. PubMed ID: 34069602
[TBL] [Abstract][Full Text] [Related]
9. Role for ZAP-70 Signaling in the Differential Effector Functions of Rituximab and Obinutuzumab (GA101) in Chronic Lymphocytic Leukemia B Cells.
Skopelja-Gardner S; Jones JD; Hamilton BJ; Danilov AV; Rigby WFC
J Immunol; 2017 Aug; 199(4):1275-1282. PubMed ID: 28710251
[TBL] [Abstract][Full Text] [Related]
10. Ligand binding but undetected functional response of FcR after their capture by T cells via trogocytosis.
Hudrisier D; Clemenceau B; Balor S; Daubeuf S; Magdeleine E; Daëron M; Bruhns P; Vié H
J Immunol; 2009 Nov; 183(10):6102-13. PubMed ID: 19841164
[TBL] [Abstract][Full Text] [Related]
11. Induction of interleukin-6 production by rituximab in human B cells.
Jones JD; Hamilton BJ; Skopelja S; Rigby WF
Arthritis Rheumatol; 2014 Nov; 66(11):2938-46. PubMed ID: 25080282
[TBL] [Abstract][Full Text] [Related]
12. Macrophage-Mediated Trogocytosis Leads to Death of Antibody-Opsonized Tumor Cells.
Velmurugan R; Challa DK; Ram S; Ober RJ; Ward ES
Mol Cancer Ther; 2016 Aug; 15(8):1879-89. PubMed ID: 27226489
[TBL] [Abstract][Full Text] [Related]
13. Lymphocytes and Trogocytosis-Mediated Signaling.
Reed J; Reichelt M; Wetzel SA
Cells; 2021 Jun; 10(6):. PubMed ID: 34204661
[TBL] [Abstract][Full Text] [Related]
14. Analyses of CD20 monoclonal antibody-mediated tumor cell killing mechanisms: rational design of dosing strategies.
Taylor RP; Lindorfer MA
Mol Pharmacol; 2014 Nov; 86(5):485-91. PubMed ID: 24944188
[TBL] [Abstract][Full Text] [Related]
15. Bone Marrow Endothelial Cells Take Up Blood-Borne Immune Complexes via Fcγ Receptor IIb2 in an Erythropoietin-Dependent Manner.
Ito T; Kometani K; Minato N; Hamazaki Y
J Immunol; 2020 Oct; 205(8):2008-2015. PubMed ID: 32907997
[TBL] [Abstract][Full Text] [Related]
16. Engineering Receptor Expression on Natural Killer Cells Through Trogocytosis.
Somanchi A; Lee DA; Somanchi SS
Methods Mol Biol; 2016; 1441():253-65. PubMed ID: 27177672
[TBL] [Abstract][Full Text] [Related]
17. Antibody isotype-specific engagement of Fcgamma receptors regulates B lymphocyte depletion during CD20 immunotherapy.
Hamaguchi Y; Xiu Y; Komura K; Nimmerjahn F; Tedder TF
J Exp Med; 2006 Mar; 203(3):743-53. PubMed ID: 16520392
[TBL] [Abstract][Full Text] [Related]
18. Fcgamma receptor-dependent effector mechanisms regulate CD19 and CD20 antibody immunotherapies for B lymphocyte malignancies and autoimmunity.
Tedder TF; Baras A; Xiu Y
Springer Semin Immunopathol; 2006 Dec; 28(4):351-64. PubMed ID: 17091246
[TBL] [Abstract][Full Text] [Related]
19. Possible implication of Fc γ receptor-mediated trogocytosis in susceptibility to systemic autoimmune disease.
Masuda S; Iwasaki S; Tomaru U; Baba T; Katsumata K; Ishizu A
Clin Dev Immunol; 2013; 2013():345745. PubMed ID: 24093044
[TBL] [Abstract][Full Text] [Related]
20. Capture of target cell membrane components via trogocytosis is triggered by a selected set of surface molecules on T or B cells.
Hudrisier D; Aucher A; Puaux AL; Bordier C; Joly E
J Immunol; 2007 Mar; 178(6):3637-47. PubMed ID: 17339461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]